Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/20616| Title: | Neoadjuvant as Future for Drug Development in Breast Cancer-Letter | Authors: | BUYSE, Marc BURZYKOWSKI, Tomasz Saad, Everardo D. |
Issue Date: | 2016 | Publisher: | AMER ASSOC CANCER RESEARCH | Source: | CLINICAL CANCER RESEARCH, 22 (1), p. 268-268 | Notes: | [Buyse, Marc] Int Inst Drug Dev, San Francisco, CA USA. [Buyse, Marc; Burzykowski, Tomasz] Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat I BioSt, Hasselt, Belgium. [Burzykowski, Tomasz; Saad, Everardo D.] Int Inst Drug Dev, Louvain La Neuve, Belgium. [Saad, Everardo D.] Dendrix Res, Sao Paulo, Brazil. | Document URI: | http://hdl.handle.net/1942/20616 | ISSN: | 1078-0432 | e-ISSN: | 1557-3265 | DOI: | 10.1158/1078-0432.CCR-15-1047 | ISI #: | 000367550300030 | Category: | A1 | Type: | Journal Contribution | Validations: | ecoom 2017 |
| Appears in Collections: | Research publications |
Show full item record
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.